Your browser doesn't support javascript.
loading
An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.
Lewis, J D; Lichtenstein, G R; Stein, R B; Deren, J J; Judge, T A; Fogt, F; Furth, E E; Demissie, E J; Hurd, L B; Su, C G; Keilbaugh, S A; Lazar, M A; Wu, G D.
Affiliation
  • Lewis JD; Division of Gastroenterology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia 19104-6021, USA.
Am J Gastroenterol ; 96(12): 3323-8, 2001 Dec.
Article in En | MEDLINE | ID: mdl-11774944
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Transcription Factors / Colitis, Ulcerative / Receptors, Cytoplasmic and Nuclear / Thiazolidinediones Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Gastroenterol Year: 2001 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Transcription Factors / Colitis, Ulcerative / Receptors, Cytoplasmic and Nuclear / Thiazolidinediones Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Gastroenterol Year: 2001 Document type: Article Affiliation country: Country of publication: